TCM Herbal Composition for Coronary Myocardial Bridge Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for coronary myocardial bridge, including drug therapy and surgical interventions, have limitations such as poor efficacy, high risk, high cost, and complications, while traditional Chinese medicine approaches are not widely applicable due to their limitations in clinical effectiveness and suitability for long-term use.
Innovation Solution
A traditional Chinese medicine composition comprising scorpion, centipede, Radix paeoniae Alba, Radix glycyrrhizae Preparata, Rhizoma chuanxiong, Radix curcumae, and Rhizoma corydalis, designed to loosen coronary myocardial bridge, improve coronary blood supply, relieve spasm, reduce blood lipid levels, and prevent coronary atherosclerosis, with a focus on regulating vital energy and blood flow.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If drug treatment (beta-blockers and calcium antagonists) is used to control heart rate and reduce myocardial contractility, then systolic coronary artery compression is reduced and coronary blood perfusion is improved, but the treatment has obvious limitations and poor curative effect
Solution Approach 1:
The patent uses a composite traditional Chinese medicine formula combining multiple herbs (Dan Shen, San Qi, Tao Ren, Nv Ji Xiao, etc.) to create a synergistic treatment approach. This composite formulation addresses the limitations of single-drug western medicine treatment by combining multiple mechanisms of action to improve curative effect and reduce treatment restrictions.
Solution Approach 2:
The patent changes the treatment parameters by using traditional Chinese medicine instead of conventional western medicine, altering the pharmacological parameters through natural compounds that regulate coronary blood flow, reduce spasm, and improve myocardial metabolism without the severe side effects and limitations of beta-blockers and calcium antagonists.
2Reliability
If supra-arterial myotomy or coronary artery bypass grafting (CABG) is performed when drug treatment is poor, then blood supply to distal myocardium is improved, but surgical difficulty is high, risk is high, and postoperative prognosis is poor
Solution Approach 1:
The patent replaces the mechanical surgical intervention (myotomy or CABG) with a pharmacological treatment approach using traditional Chinese medicine. This substitution avoids the high surgical difficulty, technical complexity, and associated risks while achieving similar therapeutic goals of improving coronary blood flow and myocardial perfusion.
Solution Approach 2:
The patent introduces traditional Chinese medicine as an intermediary treatment between drug therapy and surgery. The herbal formula acts as a mediator that can achieve blood supply improvement without requiring complex surgical procedures, thereby reducing surgical difficulty and technical requirements.
3Reliability
If conventional TCM methods are used to soothe the liver and promote circulation, then some curative effects are achieved, but the application is limited and not suitable for long-term use in elderly patients with vital energy and blood deficiency
Solution Approach 1:
The patent creates a universal TCM formula that serves multiple functions: it not only soothes the liver and promotes circulation but also tonifies vital energy and nourishes blood. This multi-functional formulation makes it suitable for long-term use in elderly patients with varying constitutions, overcoming the limitations of conventional single-function TCM treatments.
Solution Approach 2:
The patent changes the therapeutic parameters by adding tonifying and nourishing ingredients to the traditional liver-soothing formula, transforming it from a short-term symptomatic treatment to a long-term comprehensive therapy that addresses both the pathological stagnation and the underlying deficiency in elderly patients.
Data Source
AI summary
A traditional Chinese medicine composition for treating coronary myocardial bridge and an application thereof are provided. The traditional Chinese medicine composition includes the following components in parts by weight: 2-10 parts of scorpion, 2-10 parts of centipede, 15-50 parts of Radix paeoniae Alba, 5-25 parts of Radix glycyrrhizae Preparata, 10-30 parts of Rhizoma chuanxiong, 10-30 parts of Radix curcumae and 10-30 parts of Rhizoma corydalis.